Iskren K.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Evaluation of Safety, Engraftment, and Initial Clinical Activity of MB310 in Patients with Active Mild to Moderate Ulcerative Colitis: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety of Bepirovirsen in Nucleos(t)ide Analogue-Treated Patients with Chronic Hepatitis B: A Phase 3 Randomized, Double-Blind Study
- Safety and Tolerability Assessment of Dostarlimab in Adults with Chronic Hepatitis B on Nucleos(t)ide Analogue Therapy
Data & Insights
Has run more than one trial at 5 of 71 partner sites.
Specializations
Hepatitis Research
This investigator specializes in chronic hepatitis B infection management and treatment evaluation. Their research encompasses the study of novel therapeutic approaches for patients under nucleos(t)ide analogue treatment.
- Treatment durability assessment
- Functional cure strategies
- Long-term response monitoring
The investigator's work is particularly focused on evaluating innovative treatments for managing chronic HBV infection and assessing treatment durability.
Immunotherapy Studies
The investigator conducts research in immunotherapeutic approaches for viral hepatitis, including studies with novel agents like dostarlimab in chronic HBV patients.
- Safety evaluation protocols
- Tolerability assessments
- Treatment optimization
Their work includes evaluating the safety profiles of immunotherapeutic agents in hepatitis treatment contexts.
Gastrointestinal Disorders
The investigator extends their expertise to inflammatory bowel conditions, particularly ulcerative colitis. Their research includes evaluation of novel therapeutic approaches for managing gastrointestinal inflammation.
- Clinical activity assessment
- Treatment safety studies
- Therapeutic engraftment research
The focus includes investigating innovative treatments for mild to moderate ulcerative colitis cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.